ArticleOncotarget2016

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells.

Suet-Yan Kwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.